Faeth Therapeutics, Inc. (FTH) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Faeth Therapeutics, Inc. (FTH): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 51/100 — a percentile rank of Faeth Therapeutics, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $768.5M |
| EV / EBITDA | -3.7× |
| Return on equity | -113.1% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Independent of the events above — derived from Faeth Therapeutics, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact